Indications and uses
temporarily relieves minor aches and pains due to: the common cold headache backache minor pain of arthritis toothache muscular aches premenstrual and menstrual cramps temporarily reduces fever
Pain Relief
- Manufacturer
- HYVEE INC
- Effective date
- 2025-11-20
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 3
- Source
- full-release
- Hydrated at
- 2026-06-01 01:17:06
Label at a glance#
ProductPain Relief
Active ingredientACETAMINOPHEN
Label structure10 sections
Dosage and administration
do not take more than directed (see overdose warning ) adults and children 12 years and over take 2 gelcaps every 6 hours while symptoms last do not take more than 6 gelcaps in 24 hours, unless directed by a doctor do not use for more than 10 days unless directed by a doctor children under 12 years ask a doctor
Storage and handling
store between 20-25ºC (68-77ºF) retain carton for complete product information
Contacts and useful links#
Label contents#
Full prescribing information#
SPL UNCLASSIFIED SECTION
Drug Facts
Active ingredient (in each gelcap)
Acetaminophen 500 mg
Purpose
Pain reliever/fever reducer
Uses
- temporarily relieves minor aches and pains due to:
- the common cold
- headache
- backache
- minor pain of arthritis
- toothache
- muscular aches
- premenstrual and menstrual cramps
- temporarily reduces fever
Warnings
Liver warning
This product contains acetaminophen. Severe liver damage may occur if you take
- more than 4,000 mg of acetaminophen in 24 hours
- with other drugs containing acetaminophen
- 3 or more alcoholic drinks every day while using this product
Allergy alert
acetaminophen may cause severe skin reactions. Symptoms may include:
- skin reddening
- blisters
- rash
If a skin reaction occurs, stop use and seek medical help right away.
Do not use
- with any other drug containing acetaminophen (prescription or nonprescription). If you are not sure whether a drug contains acetaminophen, ask a doctor or pharmacist.
- if you are allergic to acetaminophen or any of the inactive ingredients in this product
OTC - ASK DOCTOR SECTION
Ask a doctor before use if you haveliver disease.
OTC - ASK DOCTOR/PHARMACIST SECTION
Ask a doctor or pharmacist before use if you aretaking the blood thinning drug warfarin
Stop use and ask a doctor if
- pain gets worse or lasts more than 10 days
- fever gets worse or lasts more than 3 days
- new symptoms occur
- redness or swelling is present
These could be signs of a serious condition.
OTC - PREGNANCY OR BREAST FEEDING SECTION
If pregnant or breast-feeding,ask a health professional before use.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children.
Overdose warning
In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222). Quick medical attention is critical for adults as well as for children even if you do not notice any signs or symptoms.
Directions
- do not take more than directed (see overdose warning)
| adults and children 12 years and over |
|
| children under 12 years |
|
Other information
- store between 20-25ºC (68-77ºF)
- retain carton for complete product information
Inactive ingredients
colloidal silicon dioxide, croscarmellose sodium, D&C red #33, edible ink, FD&C blue #1, FD&C red #40, FD&C yellow #6, gelatin, hydroxypropyl cellulose, hypromellose, iron oxide black, iron oxide red, iron oxide yellow, polyethylene glycol, povidone, pregelatinized starch, stearic acid, titanium dioxide
Questions?
1-844-705-4384
PRINCIPAL DISPLAY PANEL
HyVee®
NDC 42507-170-02
*Compare to the Active Ingredient in Tylenol® Extra Strength Rapid Release Gels
Extra Strength
Pain Relief
Acetaminophen, 500 mg
Pain Reliever/Fever Reducer
For Adults
Actual Size
50 GELCAPS
DailyMed RxNorm Mappings#
Product Linked Resources#
| Resource | Code type | Value | Equivalent identifiers | Source image |
|---|---|---|---|---|
| QR code link | QR Code |  hyvee.info/Pvu68r | F117002HYV_R0.jpg |
DailyMed Product Concepts#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 42507-170-01 | Pain Relief | 24 in 1 BOTTLE, PLASTIC | TABLET, COATED | 24 | 3 | |
| 42507-170-01 | Pain Relief | 1 in 1 CARTON | TABLET, COATED | 1 | 3 | |
| 42507-170-02 | Pain Relief | 1 in 1 CARTON | TABLET, COATED | 1 | 3 | |
| 42507-170-02 | Pain Relief | 50 in 1 BOTTLE, PLASTIC | TABLET, COATED | 50 | 3 | |
| 42507-170-03 | Pain Relief | 100 in 1 BOTTLE, PLASTIC | TABLET, COATED | 100 | 3 | |
| 42507-170-03 | Pain Relief | 1 in 1 CARTON | TABLET, COATED | 1 | 3 | |
| 42507-170-13 | Pain Relief | 225 in 1 BOTTLE, PLASTIC | TABLET, COATED | 225 | 3 |
Products#
Every source-derived product name is available through these pages.
- Pain Relief
- Acetaminophen
- SILICON DIOXIDE
- CROSCARMELLOSE SODIUM
- D&C RED NO. 33
- FD&C BLUE NO. 1
- FD&C RED NO. 40
- FD&C YELLOW NO. 6
- GELATIN
- HYDROXYPROPYL CELLULOSE (1600000 WAMW)
- HYPROMELLOSES
- FERROSOFERRIC OXIDE
- FERRIC OXIDE RED
- FERRIC OXIDE YELLOW
- POLYETHYLENE GLYCOL, UNSPECIFIED
- POVIDONE, UNSPECIFIED
- STARCH, PREGELATINIZED CORN
- STEARIC ACID
- TITANIUM DIOXIDE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 42507-170 | 42507-170-02, 42507-170-01, 42507-170-03, 42507-170-13 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Pain Relief | ACETAMINOPHEN | HYVEE INC | 3e61abe4-b4be-01af-e063-6394a90a8b24 | 2025-11-20 | Warnings | 42507-170-02 42507-170-01 42507-170-13 42507-170-03 42507-170 42507017013 42507017001 42507017002 42507017003 440cade8-5110-b2c9-e063-6394a90a427f 3e61abe4-b4be-01af-e063-6394a90a8b24 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.